Kawakami Hisato

カワカミヒサト | Kawakami Hisato

Affiliation and department：

Research field (1)： Hematology and oncology

Research keywords (4)：バイオマーカー , 薬物療法 , 消化器癌 , 臨床腫瘍学

Research theme for competitive and other funds (3)：

2022 - 2025 Construction of AI algorithm to identify MSI-H gastric cancer from CT images, histopathology, and clinical information
2018 - 2022 Effect of S-1 adjuvant therapy on stage II/III gastric cancer with MSI-H/dMMR tumor.
2012 - 2015 Antitumor Action of the MET Tyrosine Kinase Inhibitor in Gastric Cancer Positive for MET Amplification

Papers (143)：

Yu Sunakawa, Yasutoshi Kuboki, Jun Watanabe, Tetsuji Terazawa, Hisato Kawakami, Mitsuru Yokota, Masato Nakamura, Masahito Kotaka, Naotoshi Sugimoto, Hitoshi Ojima, et al. Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer. Targeted Oncology. 2024. 19. 1. 59-69
Seiichiro Mitani, Yosuke Kito, Kaori Hino, Kentaro Kawakami, Naoki Izawa, Fumiyasu Hanamura, Yoshiyuki Yamamoto, Hirokazu Shoji, Azusa Komori, Shogen Boku, et al. Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study. Targeted oncology. 2023. 18. 5. 707-715
Yutaka Kimura, Hisato Kawakami, Shigeyuki Tamura, Kazumasa Fujitani, Jin Matsuyama, Hiroshi Imamura, Shohei Iijima, Daisuke Sakai, Yukinori Kurokawa, Toshio Shimokawa, et al. Effect of the number of cycles of docetaxel + S-1 therapy on long-term survival in adjuvant chemotherapy for stage III gastric cancer. A pooled analysis of the OGSG0604 and OGSG1002 trials. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2023. 26. 5. 788-797
Hiroki Yukami, Hisato Kawakami, Toshifumi Yamaguchi, Daisuke Sakai, Toshio Shimokawa, Yukinori Kurokawa, Masahiro Goto, Taroh Satoh. Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106). International journal of clinical oncology. 2023. 28. 9. 1176-1182
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Yoshinori Kagawa, Naoki Takahashi, et al. Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit study. Cancer medicine. 2023

ｍore...

MISC (187)：

Satoshi Yuki, Yu Sunakawa, Kentaro Yamazaki, Hiromichi Shirasu, Hiroya Taniguchi, Toshiki Masuishi, Manabu Shiozawa, Hideaki Bando, Tomohiro Nishina, Hisateru Yasui, et al. Analysis of plasma angiogenesis factors on the efficacy of first-line (1L) chemotherapy (chemo) combined with biologics in RAS wild-type metastatic colorectal cancer (mCRC): Results from GI-SCREEN CRC Ukit study. JOURNAL OF CLINICAL ONCOLOGY. 2022. 40. 16
幕谷悠介, 川上尚人, 辻川敬裕, 家根由典, 牛嶋北斗, 原谷浩司, 吉岡康多, 和田聡明, 岩本哲好, 大東弘治, et al. MMP14発現が腫瘍免疫微小環境に与える影響. 日本外科学会定期学術集会(Web). 2022. 122nd
Kimio Yonesaka, Junko Tanizaki, Osamu Maenishi, Hisato Kawakami, Kaoru Tanaka, Hidetoshi Hayashi, Masayuki Takeda, Kazuko Sakai, Maki Kobayashi, Ryoto Yoshimoto, et al. EGFR inhibitor upregulates HER3 expression and enhances the efficacy of anti-HER3 antibody drug conjugate U3-1402. ANNALS OF ONCOLOGY. 2021. 32. S296-S296
黒崎隆, 川上尚人. 【消化管がん】胃がん・大腸がんに対するADCの展開. 腫瘍内科. 2021. 27. 6. 648-654
川上尚人, 緒方壮太. BRAF変異陽性大腸癌の新たな治療戦略. 癌と化学療法. 2021. 48. 6. 787-795

ｍore...

Education (2)：

2010 - 2013 近畿大学大学院医学部
1997 - 2003 Kumamoto University School of Medicine

Professional career (1)：

医学博士 (近畿大学大学院)

Work history (5)：

2016/10 - 現在 Kindai University
2014/07 - 2016/09 Mayo Clinic, Rochester
2010/04 - 2013/06 Kindai University
2005/05 - 2010/03 大阪赤十字病院消化器科
2004/03 - 2005/04 京都大学医学部附属病院

Committee career (9)：

2023/04 - 大腸癌研究会大腸癌治療ガイドライン委員
2023/04 - 日本胃癌学会倫理委員会委員
2023/04 - 日本胃癌学会 Patient Advocacy委員会委員
2022/04 - 日本胃癌学会患者用ガイドライン作成委員会委員
- 2021/03 厚労科研「3学会合同「がんゲノムネット」を用いた、国民への「がんゲノム医療」に関する教育と正しい情報伝達に関する研究」分担研究者

Show all

Awards (5)：

2022/01 - deleteC 2021 deleteC Cancer Treatment Research Grant
2014/06 - Harvard Medical School, Global Clinical Scholars Research Training Program: Certificated
2014/03 - 上原記念生命科学財団海外留学助成金
2013 - The 2nd Japan Taiwan Oncology Phase I Conference Travel Award
2013 - 日本臨床腫瘍学会奨励賞

Association Membership(s) (10)：

日本臨床腫瘍学会 , JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY , JAPANESE SOCIETY OF GASTROENTEROLOGY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE , European Society for Medical Oncology , American Society of Clinical Oncology , 日本遺伝性腫瘍学会 , 日本食道学会 , 日本胃癌学会 , 日本がん分子標的治療学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page